Moreover, since DC, M1 macrophages, and Th2 have different mechanisms to directly or indirectly inhibit or kill cancer cells, increased SLC25A26 expression may promote the development of GBMLGG, SKCM, UVM, and COADREAD, whereas decreased SLC25A26 expression is beneficial to inhibit or kill them. Here, SLC25A26 is linked to cancer.